Study Summary
This trial is testing if a drug called rIFN-y is safe and effective in treating patients with candidemia, which is a blood infection.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 12 Secondary · Reporting Duration: through intervention completion, an average at day 11 and 2 and 4 weeks after intervention completion
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Standard of care
1 of 2
Interferon-Gamma
1 of 2
Active Control
200 Total Participants · 2 Treatment Groups
Primary Treatment: Interferon-Gamma · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are investigators actively looking for participants for this experiment?
"Yes, an examination of the clinicaltrials.gov website indicates that this study is actively recruiting patients. According to the information available, the trial was first posted on March 15th, 2022 and was last updated on March 14th, 2022. The research team is looking for 200 individuals to take part in the study at a single site." - Anonymous Online Contributor
To the best of your knowledge, does anything like this exist?
"At the moment, there are 9 ongoing studies on Interferon-Gamma being conducted in 13 cities and 8 countries. The first study was completed way back in 2011 by BioMérieux. That particular trial only involved 20 patients, but it did manage to reach Phase 3 approval. In total, 25 studies have been done since then." - Anonymous Online Contributor
How many participants are involved in this research project?
"Yes, this research study is looking for volunteers at the moment. The listing was put up on March 15th, 2022 and updated March 14th, 2022. They are trying to find 200 individuals total from one location." - Anonymous Online Contributor
Are there any risks that come with treatment by Interferon-Gamma?
"Interferon-Gamma was given a safety score of 2. This is because, although there is data supporting its safety, there is none yet backing up claims of efficacy in Phase 2 trials." - Anonymous Online Contributor
Could you give some more examples of where Interferon-Gamma has been used in other medical research?
"Currently, there are 9 different Interferon-Gamma trials underway. 1 of these is in Phase 3. Most of the testing for this treatment is happening in Madison, Wisconsin; however, clinical research regarding Interferon-Gamma is being conducted at 39 different locations." - Anonymous Online Contributor